thyssenkrupp nucera AG (NCH2) Fair Value & Analysis
Industrials · DE · Market cap €1.1B
Fair value as of: Jun 24, 2026
From 22 valuation models · updated 8 days ago
Share price −11.6% over the past month.
Price vs Fair Value (12 months)
12‑month range €6.90 – €11.63 · fair‑value band €5.80 – €6.21 · the €7.51 price screens above the €6.00 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
thyssenkrupp nucera AG (NCH2) currently trades at €7.51, while our model-based Fair Value estimate is €6.00 — implying the stock looks roughly 20.1% overvalued today. We read business quality at 45/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, thyssenkrupp nucera AG generated revenue of €730M at a net margin of -1.0%. Revenue declined 43.9% year over year. It earns a return on equity of -1.0%. The balance sheet holds a net cash position of €656M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
thyssenkrupp nucera AG & Co. KGaA engages in the development, engineering, procurement, commissioning, and licensing of electrolysis technologies in Germany, Saudi Arabia, Sweden, the United States, and internationally. It operates through the Chlor-Alkali (CA) and Green Hydrogen (gH2) segments. The company is involved in the development, planning, and construction of new-build electrolysis plants for producing green hydrogen for industrial applications; provision of services for chlor-alkali electrolysis, such as planning and construction of new plants. It also offers the BM 2.7 single-element technology and BiTAC filter press technology. The company was formerly known as thyssenkrupp Uhde Chlorine Engineers GmbH. The company was founded in 1960 and is headquartered in Dortmund, Germany. thyssenkrupp nucera AG & Co. KGaA operates as a subsidiary of Thyssenkrupp Projekt 1 GmbH.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
thyssenkrupp nucera AG reported revenue of €845M in FY2025 versus €319M in FY2021, a compound +27.5%/yr. Reported net income was €4.6M in FY2025, compounding −31.8%/yr from FY2021.
Is NCH2 fairly valued? → Check now
Similar stocks
6 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| GE Vernova Inc GEV | $867.09 | $297.82 | -66% |
| SIEGY SIEGY | $155.10 | $88.93 | -43% |
| SMAWF SMAWF | $307.12 | $176.28 | -43% |
| SMNS SMNS | C$31.76 | C$22.91 | -28% |
| SIE SIE | €258.40 | €144.67 | -44% |
| Schneider Electric S.E. SBGSF | $334.00 | $148.44 | -56% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is thyssenkrupp nucera AG (NCH2) undervalued?
What is the fair value of NCH2?
What is the quality score of NCH2?
What is the revenue of thyssenkrupp nucera AG (NCH2)?
What is the net profit margin of NCH2?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.